Global Wholehealth Partners (OTCMKTS:GWHP) versus Flora Growth (NASDAQ:FLGC) Head-To-Head Analysis

Flora Growth (NASDAQ:FLGC) and Global Wholehealth Partners (OTCMKTS:GWHP) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Flora Growth and Global Wholehealth Partners, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flora Growth	1	0	1	0	2.00
Global Wholehealth Partners	0	0	0	0	0.00

Flora Growth presently has a consensus price target of $30.00, indicating a potential upside of 241.49%. Given Flora Growth’s stronger consensus rating and higher probable upside, equities analysts plainly believe Flora Growth is more favorable than Global Wholehealth Partners.

Institutional and Insider Ownership

36.0% of Flora Growth shares are owned by institutional investors. 2.3% of Flora Growth shares are owned by insiders. Comparatively, 10.3% of Global Wholehealth Partners shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Flora Growth and Global Wholehealth Partners’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Flora Growth	-32.03%	-64.02%	-34.46%
Global Wholehealth Partners	N/A	N/A	N/A

Valuation and Earnings

This table compares Flora Growth and Global Wholehealth Partners”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flora Growth	$57.61 million	0.11	-$15.91 million	($32.49)	-0.27
Global Wholehealth Partners	N/A	N/A	N/A	N/A	N/A

Global Wholehealth Partners has lower revenue, but higher earnings than Flora Growth.

Summary

Flora Growth beats Global Wholehealth Partners on 5 of the 9 factors compared between the two stocks.

About Flora Growth

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.

About Global Wholehealth Partners

Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic (IVD) test kits in the United States. The company offers approximately 125 diagnostic tests kits for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians' offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, yellow fever, and other epidemic and vector-borne diseases. The company was incorporated in 2013 and is based in Newport Beach, California.